K. J. Pittman, M. T. Aliota, and L. J. Knoll, Dual transcriptional profiling of mice and Toxoplasma gondii during acute and chronic infection, BMC Genomics, vol.15, p.806, 2014.

J. Lupberger, C. Casanova, and B. Fischer, PI4K-beta and MKNK1 are regulators of hepatitis C virus IRESdependent translation, Sci Rep, vol.5, p.13344, 2015.

J. Lupberger, M. B. Zeisel, and F. Xiao, EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy, Nat Med, vol.17, pp.589-595, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-00705829

L. Mailly, F. Xiao, and J. Lupberger, Clearance of persistent hepatitis C virus infection in humanized mice using a claudin-1-targeting monoclonal antibody, Nat Biotechnol, vol.33, pp.549-554, 2015.

N. Van-renne, R. Suarez, A. A. Duong, and F. , miR135a-5p-mediated downregulation of protein tyrosine phosphatase receptor delta is a candidate driver of HCVassociated hepatocarcinogenesis, Gut, vol.67, pp.953-962, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01837106

S. Nakagawa, L. Wei, and W. M. Song, Molecular liver cancer prevention in cirrhosis by organ transcriptome analysis and lysophosphatidic acid pathway inhibition, Cancer Cell, vol.30, pp.879-890, 2016.
URL : https://hal.archives-ouvertes.fr/inserm-02312659

A. J. Van-der-meer, J. J. Feld, and H. Hofer, Risk of cirrhosisrelated complications in patients with advanced fibrosis following hepatitis C virus eradication, J Hepatol, vol.66, pp.485-493, 2017.

R. Bartenschlager, T. F. Baumert, and J. Bukh, Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: considerations for scientists and funding agencies, Virus Res, vol.248, pp.53-62, 2018.

A. Arvey, I. Tempera, and K. Tsai, An atlas of the EpsteinBarr virus transcriptome and epigenome reveals hostvirus regulatory interactions, Cell Host Microbe, vol.12, pp.233-245, 2012.

H. R. Ramage, G. R. Kumar, and E. Verschueren, A combined proteomics/genomics approach links hepatitis C virus infection with nonsense-mediated mRNA decay, Mol Cell, vol.57, pp.329-340, 2015.

N. Hamdane, F. Jühling, and E. Crouchet, HCV induces persistent epigenetic reprogramming post sustained virological response associated with liver cancer risk, Gastroenterology, vol.156, pp.2313-2329, 2019.

D. Cara, F. Sheshachalam, A. Braverman, and N. E. , Peroxisome-mediated metabolism is required for immune response to microbial infection, Immunity, vol.47, pp.93-106, 2017.

J. Zhong, P. Gastaminza, and G. Cheng, Robust hepatitis C virus infection in vitro, Proc Natl Acad Sci U S A, vol.102, pp.9294-9299, 2005.

E. R. Verrier, S. A. Yim, and L. Heydmann, Hepatitis B virus evasion from cGAS sensing in human hepatocytes, Hepatology, vol.68, pp.1695-1709, 2018.

O. Bauhofer, A. Ruggieri, and B. Schmid, Persistence of HCV in quiescent hepatic cells under conditions of an interferon-induced antiviral response, Gastroenterology, vol.143, pp.429-438, 2012.

T. Svinkina, H. Gu, and J. C. Silva, Deep, quantitative coverage of the lysine acetylome using novel antiacetyl-lysine antibodies and an optimized proteomic workflow, Mol Cell Proteomics, vol.14, pp.2429-2440, 2015.

J. J. Trombetta, D. Gennert, and D. Lu, Preparation of singlecell RNA-Seq libraries for next generation sequencing, Curr Protoc Mol Biol, vol.107, 2014.

F. Xiao, I. Fofana, and L. Heydmann, Hepatitis C virus cellcell transmission and resistance to direct-acting antiviral agents, PLoS Pathog, vol.10, issue.5, p.1004128, 2014.

S. Picelli, O. R. Faridani, and A. K. Bjorklund, Full-length RNA-seq from single cells using Smart-seq2, Nat Protoc, vol.9, pp.171-181, 2014.

B. N. Nicolay, P. A. Gameiro, and K. Tschop, Loss of RBF1 changes glutamine catabolism, Genes Dev, vol.27, pp.182-196, 2013.

Y. Takemoto, Y. Suzuki, and R. Horibe, Gas chromatography/mass spectrometry analysis of very long chain fatty acids, docosahexaenoic acid, phytanic acid and plasmalogen for the screening of peroxisomal disorders, Brain Dev, vol.25, pp.481-487, 2003.

M. Jovanovic, M. S. Rooney, and P. Mertins, Dynamic profiling of the protein life cycle in response to pathogens, Science, vol.347, issue.6226, p.1259038, 2015.

A. Subramanian, P. Tamayo, and V. K. Mootha, Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles, Proc Natl Acad Sci U S A, vol.102, pp.15545-155450, 2005.

M. Reich, T. Liefeld, and J. Gould, Nat Genet, vol.38, pp.500-501, 2006.

A. Liberzon, C. Birger, and H. Thorvaldsdottir, The Molecular Signatures Database (MSigDB) hallmark gene set collection, Cell Syst, vol.1, pp.417-425, 2015.

T. Boldanova, A. Suslov, and M. H. Heim, Transcriptional response to hepatitis C virus infection and interferonalpha treatment in the human liver, EMBO Mol Med, vol.9, pp.816-834, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02049665

M. Martin, Cutadapt removes adapter sequences from high-throughput sequencing reads, EMBnet J, vol.17, pp.10-12, 2011.

E. Y. Chen, C. M. Tan, and Y. Kou, Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool, BMC Bioinformatics, vol.14, p.128, 2013.

B. Sainz and F. V. Chisari, Production of infectious hepatitis C virus by well-differentiated, growth-arrested human hepatoma-derived cells, J Virol, vol.80, pp.10253-10257, 2006.

I. J. Lodhi and C. F. Semenkovich, Peroxisomes: a nexus for lipid metabolism and cellular signaling, Cell Metab, vol.19, pp.380-392, 2014.

J. N. Lee, R. K. Dutta, and Y. Maharjan, Catalase inhibition induces pexophagy through ROS accumulation, Biochem Biophys Res Commun, vol.501, pp.696-702, 2018.

D. Paul, V. Madan, and R. Bartenschlager, Hepatitis C virus RNA replication and assembly: living on the fat of the land, Cell Host Microbe, vol.16, pp.569-579, 2014.

M. Yoneda, J. Hyun, and S. Jakubski, Hepatitis B virus and DNA stimulation trigger a rapid innate immune response through NF-kB, J Immunol, vol.197, pp.630-643, 2016.

J. G. Fan and G. C. Farrell, Epidemiology of non-alcoholic fatty liver disease in China, J Hepatol, vol.50, pp.204-210, 2009.

S. Kersten, B. Desvergne, and W. Wahli, Roles of PPARs in health and disease, Nature, vol.405, issue.6785, pp.421-424, 2000.

R. Roduit, J. Morin, and F. Masse, Glucose downregulates the expression of the peroxisome proliferatoractivated receptor-a gene in the pancreatic b-cell

, J Biol Chem, vol.275, pp.35799-35806, 2000.

S. Dharancy, M. Malapel, and G. Perlemuter, Impaired expression of the peroxisome proliferator-activated receptor alpha during hepatitis C virus infection, Gastroenterology, vol.128, pp.334-342, 2005.
URL : https://hal.archives-ouvertes.fr/hal-00187509

D. L. Diamond, A. J. Syder, and J. M. Jacobs, Temporal proteome and lipidome profiles reveal hepatitis C virusassociated reprogramming of hepatocellular metabolism and bioenergetics, PLoS Pathog, vol.6, issue.1, p.1000719, 2010.

I. San-millan and G. A. Brooks, Reexamining cancer metabolism: lactate production for carcinogenesis could be the purpose and explanation of the Warburg effect, Carcinogenesis, vol.38, pp.119-133, 2017.

S. K. Kwofie, U. Schaefer, and V. S. Sundararajan, HCVpro: hepatitis C virus protein interaction database, Infect Genet Evol, vol.11, pp.1971-1977, 2011.

M. Champion, K. Brennan, and T. Croonenborghs, Module analysis captures pancancer genetically and epigenetically deregulated cancer driver genes for smoking and antiviral response, EBioMedicine, vol.27, pp.156-166, 2018.

A. Mukherji, A. Kobiita, and T. Ye, Homeostasis in intestinal epithelium is orchestrated by the circadian clock and microbiota cues transduced by TLRs, Cell, vol.153, pp.812-827, 2013.

Y. Hoshida, A. Villanueva, and A. Sangiovanni, Prognostic gene expression signature for patients with hepatitis Crelated early-stage cirrhosis, Gastroenterology, vol.144, pp.1024-1030, 2013.

Y. Hoshida, A. Villanueva, and M. Kobayashi, Gene expression in fixed tissues and outcome in hepatocellular carcinoma, N Engl J Med, vol.359, pp.1995-2004, 2008.

M. Buzzai, D. E. Bauer, and R. G. Jones, The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid b-oxidation, Oncogene, vol.24, pp.4165-4173, 2005.

N. Fujiwara, H. Nakagawa, and K. Enooku, CPT2 downregulation adapts HCC to lipid-rich environment and promotes carcinogenesis via acylcarnitine accumulation in obesity, Gut, vol.67, pp.1493-1504, 2018.

X. Cao, Q. Ding, and J. Lu, MDA5 plays a critical role in interferon response during hepatitis C virus infection, J Hepatol, vol.62, pp.771-778, 2015.

M. S. Hiet, O. Bauhofer, and M. Zayas, Control of temporal activation of hepatitis C virus-induced interferon response by domain 2 of nonstructural protein 5A, J Hepatol, vol.63, pp.829-837, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01910941

O. Grunvogel, O. Colasanti, and J. Y. Lee, Secretion of hepatitis C virus replication intermediates reduces activation of Toll-like receptor 3 in hepatocytes, Gastroenterology, vol.154, pp.2237-2251, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02112499

U. Garaigorta and F. V. Chisari, Hepatitis C virus blocks interferon effector function by inducing protein kinase R phosphorylation, Cell Host Microbe, vol.6, pp.513-522, 2009.

R. Pais, E. Rusu, and D. Zilisteanu, Prevalence of steatosis and insulin resistance in patients with chronic hepatitis B compared with chronic hepatitis C and nonalcoholic fatty liver disease, Eur J Intern Med, vol.26, pp.30-36, 2015.

J. Hiscott, H. Kwon, and P. Genin, Hostile takeovers: viral appropriation of the NF-kB pathway, J Clin Invest, vol.107, pp.143-151, 2001.

A. C. Konner and J. C. Bruning, Toll-like receptors: linking inflammation to metabolism, Trends Endocrinol Metab, vol.22, pp.16-23, 2011.

G. C. Farrell, F. Haczeyni, and S. Chitturi, Pathogenesis of NASH: how metabolic complications of overnutrition favour lipotoxicity and pro-inflammatory fatty liver disease, Adv Exp Med Biol, vol.1061, pp.19-44, 2018.

Y. Miyanari, K. Atsuzawa, and N. Usuda, The lipid droplet is an important organelle for hepatitis C virus production, Nat Cell Biol, vol.9, pp.1089-1097, 2007.

S. Hofmann, M. Krajewski, and C. Scherer, Complex lipid metabolic remodeling is required for efficient hepatitis C virus replication, Biochim Biophys Acta Mol Cell Biol Lipids, vol.1863, pp.1041-1056, 2018.

K. Anjani, M. Lhomme, and N. Sokolovska, Circulating phospholipid profiling identifies portal contribution to NASH signature in obesity, J Hepatol, vol.62, pp.905-912, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01090208

J. P. Hardwick, D. Osei-hyiaman, and H. Wiland, PPAR/ RXR regulation of fatty acid metabolism and fatty acid uhydroxylase (CYP4) isozymes: implications for prevention of lipotoxicity in fatty liver disease, PPAR Res, p.952734, 2009.

M. Pawlak, P. Lefebvre, and B. Staels, Molecular mechanism of PPARa action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease, J Hepatol, vol.62, pp.720-733, 2015.

S. L. Friedman, B. A. Neuschwander-tetri, and M. Rinella, Mechanisms of NAFLD development and therapeutic strategies, Nat Med, vol.24, pp.908-922, 2018.

S. Blackham, A. Baillie, and F. Al-hababi, Gene expression profiling indicates the roles of host oxidative stress, apoptosis, lipid metabolism, and intracellular transport genes in the replication of hepatitis C virus, J Virol, vol.84, pp.5404-5414, 2010.

Y. Deng, J. Wang, and M. Huang, Inhibition of miR-148a-3p resists hepatocellular carcinoma progress of hepatitis C virus infection through suppressing c-Jun and MAPK pathway, J Cell Mol Med, vol.23, pp.1415-1426, 2019.

T. F. Baumert, M. D. , and I. U1110, Institut de Recherche sur les Maladies Virales et Hépatiques, 3 Rue Koeberlé, F-67000 Strasbourg, France. e-mail: thomas.baumert@unistra.fr, vol.37, p.24

B. Sainz and F. V. Chisari, Production of infectious hepatitis C virus by well-differentiated, growth-arrested human hepatoma-derived cells, J Virol, vol.80, pp.10253-10257, 2006.

T. Pietschmann, A. Kaul, and G. Koutsoudakis, Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras, Proc Natl Acad Sci, vol.103, pp.7408-7413, 2006.

A. Merz, G. Long, and M. S. Hiet, Biochemical and morphological properties of hepatitis C virus particles and determination of their lipidome, J Biol Chem, vol.286, pp.3018-3032, 2011.

M. B. Zeisel, G. Koutsoudakis, and E. K. Schnober, Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81, Hepatology, vol.46, pp.1722-1731, 2007.
URL : https://hal.archives-ouvertes.fr/inserm-00395706

E. R. Verrier, S. A. Yim, and L. Heydmann, Hepatitis B virus evasion from cyclic guanosine monophosphateadenosine monophosphate synthase sensing in human hepatocytes, Hepatology, vol.68, pp.1695-1709, 2018.
URL : https://hal.archives-ouvertes.fr/inserm-01981524

M. Champion, K. Brennan, and T. Croonenborghs, Module analysis captures pancancer genetically and epigenetically deregulated cancer driver genes for smoking and antiviral response, EBioMedicine, vol.27, pp.156-166, 2018.

O. Gevaert, MethylMix: an R package for identifying DNA methylation-driven genes, Bioinformatics, vol.31, pp.1839-1841, 2015.

O. Gevaert, V. Villalobos, and B. I. Sikic, Identification of ovarian cancer driver genes by using module network integration of multi-omics data, Interface Focus, vol.3, issue.4, p.20130013, 2013.

A. Subramanian, P. Tamayo, and V. K. Mootha, Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles, Proc Natl Acad Sci U S A, vol.102, pp.15545-15550, 2005.

M. Binder, G. Kochs, and R. Bartenschlager, Hepatitis C virus escape from the interferon regulatory factor 3 pathway by a passive and active evasion strategy, Hepatology, vol.46, pp.1365-1374, 2007.

R. Sumpter, Y. M. Loo, and E. Foy, Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I, J Virol, vol.79, pp.2689-2699, 2005.

J. Lupberger, N. Van-renne, and T. F. Baumert, Signaling pathways in liver disease, pp.459-468, 2015.

J. Lupberger, M. B. Zeisel, and F. Xiao, EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy, Nat Med, vol.17, pp.589-595, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-00705829

L. Zona, J. Lupberger, and N. Sidahmed-adrar, HRas signal transduction promotes hepatitis C virus cell entry by triggering assembly of the host tetraspanin receptor complex, Cell Host Microbe, vol.13, pp.302-313, 2013.

L. Mailly, F. Xiao, and J. Lupberger, Clearance of persistent hepatitis C virus infection in humanized mice using a claudin-1-targeting monoclonal antibody, Nat Biotechnol, vol.33, pp.549-554, 2015.

N. Van-renne, R. Suarez, A. A. Duong, and F. , miR135a-5p-mediated downregulation of protein tyrosine phosphatase receptor delta is a candidate driver of HCV-associated hepatocarcinogenesis, Gut, vol.67, pp.953-962, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01837106

A. Franovic, L. Gunaratnam, and K. Smith, Translational up-regulation of the EGFR by tumor hypoxia provides a nonmutational explanation for its overexpression in human cancer, Proc Natl Acad Sci U S A, vol.104, pp.13092-13097, 2007.

A. Misra, C. Pandey, and S. K. Sze, Hypoxia activated EGFR signaling induces epithelial to mesenchymal transition (EMT), PLoS One, vol.7, issue.11, p.49766, 2012.

Q. Li, C. Sodroski, and B. Lowey, Hepatitis C virus depends on E-cadherin as an entry factor and regulates its expression in epithelial-to-mesenchymal transition, Proc Natl Acad Sci U S A, vol.113, pp.7620-7625, 2016.

Y. Hoshida, A. Villanueva, and A. Sangiovanni, Prognostic gene expression signature for patients with hepatitis C-related early-stage cirrhosis, Gastroenterology, vol.144, pp.1024-1030, 2013.

R. N. Pugh, I. M. Murray-lyon, and J. L. Dawson, Transection of the oesophagus for bleeding oesophageal varices, Br J Surg, vol.60, pp.646-649, 1973.

Y. Hoshida, A. Villanueva, and M. Kobayashi, Gene expression in fixed tissues and outcome in hepatocellular carcinoma, N Engl J Med, vol.359, pp.1995-2004, 2008.

P. S. Tan, S. Nakagawa, and N. Goossens, Clinicopathological indices to predict hepatocellular carcinoma molecular classification, Liver Int, vol.36, pp.108-118, 2016.

. Lupberger, , vol.157